FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
3,327 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | ANDA | 62756-146 | 62756-0146-1362756-0146-6162756-0146-86 | — |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | ANDA | 62756-147 | 62756-0147-1362756-0147-6162756-0147-86 | — |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | ANDA | 62756-148 | 62756-0148-1362756-0148-6162756-0148-86 | — |
| Rivastigmine Tartrate |
| Rivastigmine tartrate 1.5 mg/1 |
| CapsuleOral |
| Aurobindo Pharma Limited |
| ANDA |
| 65862-648 |
| 65862-0648-0565862-0648-6065862-0648-78 |
| — |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Aurobindo Pharma Limited | ANDA | 65862-649 | 65862-0649-0565862-0649-6065862-0649-78 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Aurobindo Pharma Limited | ANDA | 65862-650 | 65862-0650-0565862-0650-6065862-0650-78 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Aurobindo Pharma Limited | ANDA | 65862-651 | 65862-0651-0565862-0651-6065862-0651-78 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | ANDA | 71209-012 | 71209-0012-0371209-0012-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | ANDA | 71209-013 | 71209-0013-0371209-0013-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | ANDA | 71209-014 | 71209-0014-0371209-0014-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | ANDA | 71209-015 | 71209-0015-0371209-0015-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | ANDA | 72241-011 | 72241-0011-0372241-0011-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | ANDA | 72241-012 | 72241-0012-0372241-0012-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | ANDA | 72241-013 | 72241-0013-0372241-0013-10 | — |
|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | ANDA | 72241-014 | 72241-0014-0372241-0014-10 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Breckenridge Pharmaceutical, Inc. | ANDA | 51991-897 | 51991-0897-30 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Breckenridge Pharmaceutical, Inc. | ANDA | 51991-898 | 51991-0898-30 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Breckenridge Pharmaceutical, Inc. | ANDA | 51991-899 | 51991-0899-30 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 63629-2064 | 63629-2064-01 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 63629-2065 | 63629-2065-01 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 63629-2066 | 63629-2066-01 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 63629-8807 | 63629-8807-01 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 63629-8846 | 63629-8846-01 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 72162-1608 | 72162-1608-03 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 72162-1609 | 72162-1609-03 | — |
|---|
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Bryant Ranch Prepack | ANDA | 72162-1610 | 72162-1610-03 | — |
|---|
| Rivelsalevonorgestrel/ethinyl estradiol and ethinyl estradiol | — | Kit | Teva Pharmaceuticals USA, Inc. | NDA authorized generic | 0093-6031 | 00093-6031-82 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen .1 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1449 | 22840-1449-0222840-1449-04 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1450 | 22840-1450-02 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen 40000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1451 | 22840-1451-0222840-1451-04 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1452 | 22840-1452-0222840-1452-04 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-4493 | 22840-4493-01 | — |
|---|
| River Birch Pollenbetula nigra | Betula nigra pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5413 | 22840-5413-0222840-5413-0422840-5413-05 | — |
|---|
| River/Red Birch Pollenbetula nigra | Betula nigra pollen .05 g/mL | InjectionCutaneous, Intradermal, Subcutaneous | Allermed Laboratories, Inc. | BLA | 49643-443 | 49643-0443-0549643-0443-1049643-0443-30+1 more | — |
|---|
| Riversol Daily Glow Mineral Tintedzinc oxide | Zinc oxide 132 mg/mL | LotionTopical | Riversol Skincare | OTC monograph drug | 72019-2035 | 72019-2035-02 | — |
|---|
| Riversol Daily Glow Mineral Untintedzinc oxide | Zinc oxide 132 mg/mL | LotionTopical | Riversol Skincare | OTC monograph drug | 72019-2033 | 72019-2033-02 | — |
|---|
| Riversol Tinted Lip Oil - Poppyzinc oxide | Zinc oxide 132 mg/mL | LotionTopical | Solesence, Inc. | OTC monograph drug | 63931-8421 | 63931-8421-02 | — |
|---|
| Riversol Tinted Lip Oil - Poppyzinc oxide | Zinc oxide 132 mg/mL | LotionTopical | Riversol | OTC monograph drug | 72019-1842 | 72019-1842-02 | — |
|---|
| Riversol Tinted Lip Oil - Popsiclezinc oxide | Zinc oxide 154 mg/mL | LotionTopical | Riversol | OTC monograph drug | 72019-2102 | 72019-2102-02 | — |
|---|
| Riversol Tinted Lip Oil - Rosewoodzinc oxide | Zinc oxide 110 mg/mL | LotionTopical | Solesence, Inc. | OTC monograph drug | 63931-2116 | 63931-2116-02 | — |
|---|
| Riversol Tinted Lip Oil - Rosewoodzinc oxide | Zinc oxide 110 mg/mL | LotionTopical | Riversol | OTC monograph drug | 72019-2116 | 72019-2116-02 | — |
|---|
| Rivflozanedosiran | Nedosiran sodium 160 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | NDA | 0169-5306 | 00169-5306-10 | — |
|---|
| Rivflozanedosiran | Nedosiran sodium 128 mg/.8mL | Injection, SolutionSubcutaneous | Novo Nordisk | NDA | 0169-5307 | 00169-5307-08 | — |
|---|
| Rivflozanedosiran | Nedosiran sodium 80 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk | NDA | 0169-5308 | 00169-5308-01 | — |
|---|
| RiVivenaloxone hydrochloride | Naloxone hydrochloride 3 mg/.1mL | SprayNasal | Harm Reduction Therapeutics, Inc. | NDA | 82954-0100 | 82954-0100-01 | — |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3026 | 00944-3026-02 | — |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3028 | 00944-3028-02 | — |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3030 | 00944-3030-02 | — |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3032 | 00944-3032-02 | — |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3034 | 00944-3034-02 | — |
|---|